Synthetic cannabinoids further rift between marijuana and hemp industries

A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.

Chart showing cannabinoid market breakdown

GOP congressman compares marijuana industry to ‘slavery’

A Republican congressman notorious for blocking federal marijuana reform nearly derailed a “historic” Capitol Hill hearing on federal legalization Tuesday when he compared the MJ industry to slavery, comments other lawmakers decried as “offensive.”

Image of a U.S. flag waving in front of the U.S. Capitol Building